Literature DB >> 28652056

Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells.

Justyna Mikuła-Pietrasik1, Paweł Uruski2, Martyna Pakuła3, Konstantin Maksin4, Sebastian Szubert5, Aldona Woźniak6, Eryk Naumowicz7, Dariusz Szpurek8, Andrzej Tykarski9, Krzysztof Książek10.   

Abstract

The cancer-promoting activity of senescent peritoneal mesothelial cells (HPMCs) has already been well evidenced both in vitro and in vivo. Here we sought to determine if ovarian cancer cells may activate senescence in HPMCs. The study showed that conditioned medium (CM) from ovarian cancer cells (OVCAR-3, SKOV-3, A2780) inhibited growth and promoted the development of senescence phenotype (increased SA-β-Gal, γ-H2A.X, 53BP1, and decreased Cx43) in HPMCs. An analysis of tumors isolated from the peritoneum of patients with ovarian cancer revealed an abundance of senescent HPMCs in proximity to cancerous tissue. The presence of senescent HPMCs was incidental when fragments of peritoneum free from cancer were evaluated. An analysis of the cells' secretome followed by intervention studies with exogenous proteins and neutralizing antibodies revealed hepatocyte growth factor (HGF) as the mediator of the pro-senescence impact of the cancer cells. The activity of cancerous CM and HGF was associated with an induction of mitochondrial oxidative stress. Signaling pathways involved in the senescence of HPMCs elicited by the cancer-derived CM and HGF included p38 MAPK, AKT and NF-κB. HPMCs that senesced prematurely in response to the cancer-derived CM promoted adhesion of ovarian cancer cells, however this effect was effectively prevented by the cell protection against oxidative stress. Collectively, our findings indicate that ovarian cancer cells can elicit HGF-dependent senescence in HPMCs, which may contribute to the formation of a metastatic niche for these cells within the peritoneal cavity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular senescence; Hepatocyte growth factor; Mesothelial cells; Ovarian cancer; Peritoneum

Mesh:

Substances:

Year:  2017        PMID: 28652056     DOI: 10.1016/j.freeradbiomed.2017.06.015

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  11 in total

Review 1.  The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.

Authors:  Sabrina J Ritch; Carlos M Telleria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

Review 2.  Two-Step Senescence-Focused Cancer Therapies.

Authors:  Cynthia J Sieben; Ines Sturmlechner; Bart van de Sluis; Jan M van Deursen
Journal:  Trends Cell Biol       Date:  2018-05-17       Impact factor: 20.808

Review 3.  Cellular Senescence in the Treatment of Ovarian Cancer.

Authors:  Zehua Wang; Haiou Liu; Congjian Xu
Journal:  Int J Gynecol Cancer       Date:  2018-06       Impact factor: 3.437

4.  Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells.

Authors:  Martyna Pakuła; Anna Witucka; Paweł Uruski; Artur Radziemski; Rafał Moszyński; Dariusz Szpurek; Konstantin Maksin; Aldona Woźniak; Stefan Sajdak; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

5.  c-Met as a new marker of cellular senescence.

Authors:  Maria Boichuck; Jonathan Zorea; Moshe Elkabets; Marina Wolfson; Vadim E Fraifeld
Journal:  Aging (Albany NY)       Date:  2019-05-13       Impact factor: 5.682

6.  Deciphering the Molecular Mechanism of Spontaneous Senescence in Primary Epithelial Ovarian Cancer Cells.

Authors:  Martyna Pakuła; Ewa Mały; Paweł Uruski; Anna Witucka; Małgorzata Bogucka; Natalia Jaroszewska; Nicoletta Makowska; Arkadiusz Niklas; Rafał Moszyński; Stefan Sajdak; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  Cancers (Basel)       Date:  2020-01-27       Impact factor: 6.639

7.  Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis.

Authors:  Szymon Rutecki; Paulina Szulc; Martyna Pakuła; Paweł Uruski; Artur Radziemski; Eryk Naumowicz; Rafał Moszyński; Andrzej Tykarski; Justyna Mikuła-Pietrasik; Krzysztof Książek
Journal:  J Ovarian Res       Date:  2022-07-26       Impact factor: 5.506

8.  CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Authors:  Long-Qiao Cao; Ya-Nan Wang; Ming Liang; Mei-Zhou Pan
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

9.  Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer.

Authors:  Sharad Purohit; Wenbo Zhi; Daron G Ferris; Manual Alverez; Lynn Kim Hoang Tran; Paul Minh Huy Tran; Boying Dun; Diane Hopkins; Bruno Dos Santos; Sharad Ghamande; Jin-Xiong She
Journal:  Cancers (Basel)       Date:  2020-10-09       Impact factor: 6.639

10.  Patient-Specific Variables Determine the Extent of Cellular Senescence Biomarkers in Ovarian Tumors In Vivo.

Authors:  Paweł Uruski; Justyna Mikuła-Pietrasik; Eryk Naumowicz; Kamila Kaźmierczak; Andrey N Gaiday; Jan Królak; Błażej Nowakowski; Rafał Moszyński; Andrzej Tykarski; Krzysztof Książek
Journal:  Biomedicines       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.